Biomarkers for Endometriosis

计划入组 100 人 · 首次发布于 2026 年 7 月 20 日

Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer

计划入组 17 人 · 首次发布于 2019 年 4 月 3 日

Expression Analysis of the COPB 2 and Bcl-2 in Early Stages of Endometrial Carcinoma

计划入组 60 人 · 首次发布于 2023 年 7 月 19 日

BCL-2 protein inhibitors (cancer)

Bcl-2-Bak protein inhibitors (cancer)

Bcl-2/Bcl-xL inhibitor (Kirin)

Protein Sciences Corporation

United States

MEREO BIOPHARMA 2 LIMITED

United Kingdom

UpJohn US 2 LLC

United States

Lisaftoclax Poised to Be First Approved Bcl-2 Inhibitor in China for Chronic Lymphocytic Leukemia

Bio-Path Holdings' BP1003 Demonstrates Therapeutic Potential in Diverse Cancers

Clinical Trials Target Residual Disease to Improve AML Outcomes